Business Performance Review

Segment Performance | Generic & CDMO business Generic API (Revenue In Millions) 4,533 4,799 5,299 5,042 CDMO (Revenue In Millions) 568 5,428 Q2 FY23 Q3 FY23 Q4 FY23 Q1 FY24 Q2 FY24 0 • 95% Generic API revenues in Q2FY24 increased by 19.7% YoY and by 7.7% QoQ Generic API business was driven by robust growth in regulated markets Regions like US, LATAM and Europe contributed to strong growth momentum 6 309 279 464 253 Q2 FY23 Q3 FY23 Q4 FY23 Q1 FY24 Q2 FY24 5% • CDMO business witnessed a de-growth of 18.1% on YoY basis driven by temporary low demand for one of the CDMO products Multiple discussions ongoing with companies globally for additional business opportunities Є Glenmark LIFE SCIENCES

View entire presentation